Verge is focused on developing therapeutics for complex diseases with high unmet need, using human genomics from patient disease tissues and machine learning.

The company has created a proprietary all-in-human CONVERGE platform, featuring one of the field’s largest and most comprehensive databases of multi-omic patient data.